Wait a second!
More handpicked essays just for you.
More handpicked essays just for you.
Coca cola marketing strategies
Coca cola marketing strategies
Coca cola marketing strategies
Don’t take our word for it - see why 10 million students trust us with their essay needs.
Recommended: Coca cola marketing strategies
Many dangers of prescription drugs are a result of the lack of government influence and supervision in the pharmaceutical industry. It is a business that has free reign to run itself (Perkins). This creates many problems for American consumers. One of these problems is the outrageously high prices of pharmaceuticals. They are nearly impossible to afford for those without insurance, or with insurance that doesn’t cover prescription drugs. Studies performed by the Kaiser Family Foundation show that, “private employer-sponsored health-insurance premiums rose 13.9% this year, the most since 1989”, a trend that is expected to continue for many years to come (Coy). The rising costs of health insurance along with the already high prices of prescription drugs make pharmaceuticals difficult for many Americans to afford. Drug companies justify high prices by saying how expensive the research and development of a new drug is. For once, this is a truthful statement by these companies. Research and development is a long and a costly process. However, drug companies are much less involved in the research and development than they would have us believe. Big drug companies actually contribute very little to the research and development of a new drug. Marcia Angell speaks on the research and development process in her book on drug companies saying, “Contrary to industry propaganda, it is almost always carried out at Universities or government research labs, either in this country or abroad.” (21-22). Professors and students in universities across the world conduct the research and develop new drugs for drug companies. Every year drug companies make huge profits providing little funding towards research and development, while their research is bei... ... middle of paper ... ...bout the company’s new asthma drug called Advair, which was nothing more than a combination of two of the company’s older medicines.” No changes were made to either drug; they were only combined and marketed with a fresh name as a new drug (Peterson 17). A pill’s color is also used as a marketing tool in an attempt to give pills a personality. IMS Health consultants said, “Pink is perceived as calming, and may be suitable for heart drugs or tranquilizers, while bold colors such as red suggest rapid action and stimulation, and may therefore be appropriate for a painkiller or antidepressant.” The same marketing tool Coca-Cola used with the color red, where the bright color represented the “crisp” taste of Coca-Cola. More focus is on the color of the pill than on what the pill does or what it treats in companies such as AstraZeneca’s marketing campaigns (Peterson 18).
In some instances, the pharmaceutical industry in the United States misleads both the public and medical professionals by participating in acts of both deceptive marketing practices and bribery, and therefore does not act within the best interests of the consumers. In America today, many people are in need of medical help. In fact,the Federal Trade Commission estimates that 75% of the population complain of physical problems (Federal Trade Commission 9). They complain, for example, of fatigue, colds, headaches, and countless other "ailments." When these symptoms strike, 65% purchase over-the-counter, or OTC, drugs.
The United States of America accounts for only 5% of the world’s population, yet as a nation, we devour over 50% of the world’s pharmaceutical medication and around 80% of the world’s prescription narcotics (American Addict). The increasing demand for prescription medication in America has evoked a national health crisis in which the government and big business benefit at the expense of the American public.
risk, for drugs and medical devices, weighing risks against benefits is at the core of
Third is performing reckonable accident errors that have been impaired on patients whereas the amount also was listed at $1.7 Million from 2008.Fourth the U.S. reckless spends about 100-200 billion a year in curing uninsured patients. Fifth, the most commonly talked about drug of all is tobacco, which amounts to about 96 billion. Healthcare not only does give patients the importance of everything but we also have technology along with so many life-enhancing benefits is ridiculously high and is way over the line. Which is why so many of our medical learners are not being trained enough to understand the importance of procuring and delivering prescription drugs that have cost about 1.3 billion dollars. The Question we should ask ourselves this how is it going to look when those are in need of a serious medical issue of having what’s required of them to take in order to ease their pain.
Why are the prices so high? Some critics of the drug companies argue that the larger firms are ripping off the American public, are dishonest and, in some cases, unsafe. On the other hand, there are health care workers such as doctors and their supporters who claim that research and testing for drugs costs money. This supposedly justifies their prices for their products. Also, as an argument to their side, they say that their practice is a benefit to the improvement to mankind. It is a life saving business, but are these prices justified? As one can see, this is a very important issue in medicine today. It affects everyone involved with medicine, which is much of the American public. It also affects the physicians and drug makers.
The point at which they decide to produce will rest on their own adversity of revenue, risk and effort. The company also needs to know the price elasticity of the curve: the greater the price elasticity, the more a company such as Pfizer will struggle to establish high prices and a high volume. Although monopolies appear damaging at times, there are arguments that they are an advantage to society. Monopolies in the pharmaceutical industry drive companies to pursue research and development (R&D) efforts to gain new patents. According to a 1992 study, among the 24 U.S. Industry groups, pharmaceuticals dedicated 16.6% of their amounts to basic research, while all other industries averaged at 5.3% (Sherer 1307).
Pharmaceutical patents are patents for inventions within the pharmaceutical industry. Patents give exclusive rights for an invention for a product or a process of making a product [1]. There are many aspects to patents in the pharmaceutical industry that are both pros and cons; it just depends on what industry you are in. Pharmaceutical companies take out patents so they can regulate the market and restrict competition from other companies. By obtaining patents pharmaceutical companies also attract investment. In addition to this pharmaceutical companies can also regulate the price of the drug as they will be the only company selling that drug. However these aspects of patents can adversely affect the generics industry. The generics industry cannot make or sell drugs that are patented but once a patent licence expires, both the generics industry and the WHO see increased benefits as drugs become more widely available around the world (i.e. developing countries) at a lower price. Here we will discuss the pros and cons of patents from the point of view of the pharmaceutical industry, generics industry and the WHO.
The policy issue I have identified is prescription drug coverage. This interests me because prescription drugs are a major part of modern medicine. They serve as compliments to medical procedures; substitutes for surgery or other procedures; and new treatments where there were none previously (Oliver, Lee & Lipton, 2004). As the medical community’s understanding of the human body increases the possibility for new pharmaceutical interventions will increase.
The Economist, a highly respected magazine that was started in the mid-1800s, in their article, Why Drug Prices in America Are so High, published on their website, the Economist, addresses the topic absurd drug costs in America and constructs that it is legal for the companies to raise the prices. They support this claim by stating that American companies can “ set whatever official price they like” (Why Drug Prices in America Are so High), and by saying, “Insurers and the government then whittle down that price using methods that vary from one type of patient to the next” (Why Drug Prices in America Are so High). The Economist’s purpose is to clarify why the drug prices are over the top-in the opinion of the general public-in order to calm
does not spend adequate money on preventative healthcare, especially considering that millions of Americans are diagnosed with diseases that can be cheap to prevent, but expensive to treat. Approximately half of adult Americans suffer from chronic diseases that require long-term treatment; some of the most common include heart disease, cancer, obesity, and diabetes. Certainly, these ailments are not always completely preventable, but in most cases, taking care of one’s health can prevent the acquiring of heart disease and obesity. With the U.S. now using both public and private based health insurance, this does not hinder private companies from implementing supply and demand. Another driving force of the high healthcare costs in the U.S. is the prescription drug market. The United States is one of only two countries in the world that allows millions of dollars each year to contribute to the advertising of prescription drugs. Of course, the cost of advertising causes the price of certain drugs to rise, Americans could benefit from laws prohibiting this type of health-related spending, and they could also benefit from government regulated healthcare
Manufacturers that sell dangerous medications can face government fines, as well as lawsuits from injured consumers. Experienced attorneys recognize that the only message these companies understand are ones that affect their pocketbook. The manufacturers of popular drugs all have had to pay the price for their dangerous actions at one time or another.]”
By examining historical factors that affect the regulation of the industry, reasons for the rising costs and lower productivity can be determined. Recent trends and emerging fields that have contributed to the causes for the rising costs of drug development, as well as worked to improve efficiency and reduce costs, within the drug ...
Prescription drugs prices are becoming a huge barrier for many patients. The high cost issue affects different kinds of groups such as people living under low-income. (Gellad et al., 2009) Even though many low-income people receives coverage through government programs and also obtain many drug benefits, when it comes to people who are not covered, they are the ones that are more likely to be affected by this issue (Gellad et al., 2009). People who are not covered would have to pay the full price that is charged by the pharmacies (Gellad et al., 2009). Due to the discounts that are made by insurance companies, customers who are paying by cash are charged way higher prices for their medications than compared to insured counterparts (Gellad et
What is a pharmaceutical company’s main objective? You might think it is to cure people of illnesses or even make people healthier. However new research and public information shows that while they work in health care health is not what they are starting distribute. “A pharmaceutical company, or drug company, is a commercial business licensed to research, develop, market and/or distribute drugs, most commonly in the context of healthcare. They can deal in generic and/or brand medications.” Although they are a vital part of any economy and health field there are many problems with in the medical industry such as (a) the focus of money, (b) drug abuse, (c) over consumption and (d) severe side effects. Pharmaceutical companies should be better managed and regulated in the United States. There is an unethical balance in how the industry is controlled. They are in it for profit not treatment.
pharmaceutical companies that profit from the high costs of drugs. It is evident that there is a